NEW YORK — Boston Scientific Corp. agreed to pay $188.7 million to settle claims by most U.S. states that it deceptively marketed its surgical mesh devices to consumers. The settlement with 47 states and Washington, D.C. was announced on Tuesday …
Source: Claims Journal